Kaplan–Meier survival curves further demonstrate that lung cancer patients with high CR‐1 and high VEGF have substantially shorter PFS and OS, compared to those with low CR‐1 and low VEGF patients (Figure 3A–D). This evidence concerns the gene VEGFA and lung cancer.